Cardiovascular Agents
Research News and Information

Sunday, November 22, 2009

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

4 Nov 2009 OBJECTIVE: To evaluate the benefits and harms of low dose aspirin in people with diabetes and no cardiovascular disease. DESIGN: Meta-analysis of randomised controlled trials. DATA SOURCES: Medline (1966-November 2008), the Cochrane central register ... Read more...

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

29 Sep 2009 The cardiovascular effects of epoxyeicosatrienoic acids (EETs) include vasodilation, antimigratory actions on vascular smooth muscle cells and anti-inflammatory actions. These endogenous lipid mediators are broken down into diols by soluble epoxide ... Read more...

Therapeutic options and patterns of prescription in chronic venous disorders: results of a 3-year survey in Italy.

29 Sep 2009 OBJECTIVES: To assess self-management of chronic venous disorders (CVDs) in a selected Italian population and the pattern of prescription by selected Italian phlebologists. DESIGN: Cross-sectional study carried out between 2003 and 2005. MATERIALS: ... Read more...

Latest indexed articles for 'Cardiovascular Agents'

These are the very latest articles for this heading:

• Aspirin for primary prevention of vascular disease in people with diabetes. 4 Nov 2009
• Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. 4 Nov 2009
• Recurrence of local anesthetic cardiac toxicity or hypokalemia? 30 Oct 2009
• Generic drugs revisited. 17 Oct 2009
• Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. 29 Sep 2009
• Therapeutic options and patterns of prescription in chronic venous disorders: results of a 3-year survey in Italy. 29 Sep 2009
• Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial. 27 Sep 2009
• An adaptive transfer function for deriving the aortic pressure waveform from a peripheral artery pressure waveform. 23 Sep 2009
• Microvascular oxygen delivery-to-utilization mismatch at the onset of heavy-intensity exercise in optimally treated patients with CHF. 2 Sep 2009
• [Chronic coronary heart disease. Family practice therapy is restored] Sep 2009
• Safety of electroconvulsive therapy in patients with unrepaired abdominal aortic aneurysm: report of 8 patients. 30 Aug 2009
• Cognitive decline after invasive intervention in cardiovascular disease: is it drug related? 30 Aug 2009
• Letter regarding levosimendan in a rat model of severe verapamil poisoning. 30 Aug 2009
• Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction. 30 Aug 2009
• Three-year prognosis of Japanese patients with ST-elevation myocardial infarction treated with sirolimus-eluting stents. 30 Aug 2009
• [Controversies in hypertrophic cardiomyopathy] 30 Aug 2009
• Heart failure in children: part II: diagnosis, treatment, and future directions. 30 Aug 2009
• Overview of emerging pharmacotherapy in chronic heart failure. 30 Aug 2009
• Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years. 30 Aug 2009
• How to improve cardiovascular diseases prevention in Europe? 30 Aug 2009

See a longer list of these articles.

Technical information about 'Cardiovascular Agents'

Definition: Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.

Registry Number: 0

Descriptor UI: D002317

Alternative terms: Cardiovascular Agents; Agents, Cardiovascular; Cardiovascular Drugs; Drugs, Cardiovascular;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.411;

Online Note: consider also CARDIOVASCULAR SYSTEM /DE

History Note: 79; was NON MESH before 1979